Sentiment-Signal
22,1
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Unternehmen & Branche
| Name | Teladoc Health, Inc. |
|---|---|
| Ticker | TDOC |
| CIK | 0001477449 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
| SIC | 8011 · Services-Offices & Clinics of Doctors of Medicine |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,06 Mrd. USD |
| Beta | 2,08 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 2,529,977,000 | -200,322,000 | -1.14 | 2,858,300,000 | 1,385,706,000 |
| 2025-09-30 | 10-Q | 626,439,000 | -49,507,000 | -0.28 | 2,878,547,000 | 1,392,115,000 |
| 2025-06-30 | 10-Q | 631,900,000 | -32,660,000 | -0.19 | 2,894,004,000 | 1,422,139,000 |
| 2025-03-31 | 10-Q | 629,369,000 | -93,012,000 | -0.53 | 3,444,445,000 | 1,427,030,000 |
| 2024-12-31 | 10-K | 2,569,574,000 | -1,001,245,000 | -5.87 | 3,516,524,000 | 1,491,079,000 |
| 2024-09-30 | 10-Q | 640,508,000 | -33,276,000 | -0.19 | 3,528,581,000 | 1,507,702,000 |
| 2024-06-30 | 10-Q | 642,444,000 | -837,671,000 | -4.92 | 3,523,638,000 | 1,502,086,000 |
| 2024-03-31 | 10-Q | 646,131,000 | -81,889,000 | -0.49 | 4,320,756,000 | 2,288,898,000 |
| 2023-12-31 | 10-K | 2,602,415,000 | -220,368,000 | -1.34 | 4,392,369,000 | 2,326,073,000 |
| 2023-09-30 | 10-Q | 660,238,000 | -57,073,000 | -0.35 | 4,327,973,000 | 2,294,050,000 |
| 2023-06-30 | 10-Q | 652,406,000 | -65,177,000 | -0.40 | 4,316,405,000 | 2,295,144,000 |
| 2023-03-31 | 10-Q | 629,244,000 | -69,228,000 | -0.42 | 4,309,147,000 | 2,291,226,000 |
| 2022-12-31 | 10-K | 2,406,840,000 | -13,659,531,000 | -84.60 | 4,345,355,000 | 2,307,745,000 |
| 2022-09-30 | 10-Q | 611,402,000 | -73,476,000 | -0.45 | 8,103,965,000 | 6,052,661,000 |
| 2022-06-30 | 10-Q | 592,379,000 | -3,101,461,000 | -19.22 | 8,102,775,000 | 6,084,650,000 |
| 2022-03-31 | 10-Q | 565,350,000 | -6,674,523,000 | -41.58 | 11,092,337,000 | 9,142,610,000 |
| 2021-12-31 | 10-K | 2,032,707,000 | -428,793,000 | -2.73 | 17,734,608,000 | 16,045,757,000 |
| 2021-09-30 | 10-Q | 521,658,000 | -84,340,000 | -0.53 | 17,652,579,000 | 15,987,582,000 |
| 2021-06-30 | 10-Q | 503,139,000 | -133,819,000 | -0.86 | 17,611,119,000 | 16,001,070,000 |
| 2021-03-31 | 10-Q | -199,649,000 | -1.31 | 17,582,358,000 | 15,829,498,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Catapano Joseph Ronald | Officer, Chief Accounting Officer | Open Market Sale | -675 | 5.11 | -3,451.95 | -5,3% | |
| 2026-03-11 | DIVITA CHARLES III | Director, Officer, CHIEF EXECUTIVE OFFICER | Open Market Sale | -27,731 | 5.49 | -152,243.19 | -234,4% | |
| 2026-03-03 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -25,086 | 4.98 | -124,978.45 | -192,4% | |
| 2026-03-02 | DIVITA CHARLES III | Director, Officer, CHIEF EXECUTIVE OFFICER | Open Market Sale | -50,145 | 5.12 | -256,591.97 | -395,0% | |
| 2026-03-02 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -16,314 | 5.12 | -83,478.74 | -128,5% | |
| 2026-03-02 | Nueno Carlos | Officer, President, International | Open Market Sale | -20,165 | 5.12 | -103,184.31 | -158,8% | |
| 2026-03-02 | Vandervoort Adam C | Officer, CHIEF LEGAL OFFICER, SECRETARY | Open Market Sale | -27,083 | 5.12 | -138,583.71 | -213,3% | |
| 2026-03-02 | Bliss Kelly | Officer, President, U.S. Group Health | Open Market Sale | -26,647 | 5.12 | -136,352.70 | -209,9% | |
| 2026-03-02 | Catapano Joseph Ronald | Officer, Chief Accounting Officer | Open Market Sale | -1,333 | 5.12 | -6,820.96 | -10,5% | |
| 2026-01-05 | Catapano Joseph Ronald | Officer, Chief Accounting Officer | Open Market Sale | -758 | 7.15 | -5,415.91 | -8,3% | |
| 2025-12-11 | DIVITA CHARLES III | Director, Officer, CHIEF EXECUTIVE OFFICER | Open Market Sale | -17,138 | 7.63 | -130,836.63 | -201,4% | |
| 2025-12-03 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -4,209 | 7.48 | -31,483.32 | -48,5% | |
| 2025-12-02 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -2,324 | 7.49 | -17,402.11 | -26,8% | |
| 2025-12-02 | Vandervoort Adam C | Officer, CHIEF LEGAL OFFICER, SECRETARY | Open Market Sale | -5,720 | 7.49 | -42,831.36 | -65,9% | |
| 2025-12-02 | Nueno Carlos | Officer, President, International | Open Market Sale | -3,897 | 7.49 | -29,180.74 | -44,9% | |
| 2025-12-02 | Bliss Kelly | Officer, President, U.S. Group Health | Open Market Sale | -4,582 | 7.49 | -34,310.02 | -52,8% | |
| 2025-11-14 | Paulus Kenneth H | Director | Open Market Purchase | 10,000 | 6.94 | 69,400.00 | +106,8% | |
| 2025-10-02 | Catapano Joseph Ronald | Officer, Chief Accounting Officer | Open Market Sale | -2,972 | 7.89 | -23,434.22 | -36,1% | |
| 2025-09-11 | DIVITA CHARLES III | Director, Officer, CHIEF EXECUTIVE OFFICER | Open Market Sale | -16,787 | 7.59 | -127,435.15 | -196,2% | |
| 2025-09-03 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -4,149 | 7.59 | -31,490.91 | -48,5% | |
| 2025-09-02 | Nueno Carlos | Officer, President, International | Open Market Sale | -3,998 | 7.59 | -30,324.83 | -46,7% | |
| 2025-09-02 | Bliss Kelly | Officer, President, U.S. Group Health | Open Market Sale | -4,700 | 7.59 | -35,649.50 | -54,9% | |
| 2025-09-02 | Murthy Mala | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -12,846 | 7.59 | -97,436.91 | -150,0% | |
| 2025-09-02 | Vandervoort Adam C | Officer, CHIEF LEGAL OFFICER, SECRETARY | Open Market Sale | -5,867 | 7.59 | -44,501.20 | -68,5% | |
| 2025-09-02 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -2,383 | 7.59 | -18,075.06 | -27,8% | |
| 2025-06-03 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -4,174 | 6.91 | -28,842.34 | -44,4% | |
| 2025-06-02 | Rodrigues Fernando M. | Officer, President of BetterHelp | Open Market Sale | -2,358 | 6.86 | -16,175.88 | -24,9% | |
| 2025-06-02 | Bliss Kelly | Officer, President, U.S. Group Health | Open Market Sale | -4,653 | 6.86 | -31,919.58 | -49,1% | |
| 2025-06-02 | Nueno Carlos | Officer, President, International | Open Market Sale | -3,958 | 6.86 | -27,151.88 | -41,8% | |
| 2025-06-02 | Vandervoort Adam C | Officer, CHIEF LEGAL OFFICER, SECRETARY | Open Market Sale | -5,808 | 6.86 | -39,842.88 | -61,3% | |
| 2025-06-02 | Murthy Mala | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -13,856 | 6.86 | -95,052.16 | -146,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.